Postdoctoral Position in Immunology-Brad Jones Lab
The Jones Lab at Weill Cornell Medicine in New York City https://joneslab.weill.cornell.edu is seeking postdoctoral candidates with backgrounds in T-cell immunology, vaccines/immunotherapy, and/or HIV persistence to lead projects investigating both: i) Novel mechanisms by which cells that harbor HIV reservoirs (in ARV-treated donors) resist elimination by cytotoxic T-cells and NK cells, and ii) Mechanistic underpinnings of durable CD8+ T-cell mediated control of viral replication observed in both pre-clinical and clinical studies, in particular following treatment with broadly neutralizing antibodies.
These projects are funded by multiple NIH grants, including a Martin Delaney collaboratory co-led by Dr. Jones, and will be conducted in close collaboration with Marina Caskey (Rockefeller University), Morgan Huse (Memorial Sloan Kettering), and Darrell Irvine (MIT). They will integrate advanced tissue culture techniques and multi-omics approaches (supported by a bioinformatics team), along with unique and valuable samples/cohorts with the dual aims of both advancing therapeutics approaches to cure HIV, and of generating fundamental immunological insights.
Our well-funded, diverse, and collaborative laboratory is a vibrant and stimulating environment for scientific growth and fostering the independent careers of postdoctoral trainees.
- Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells. JCI, 2018. PMID: 29355843; BCL-2 antagonism sensitizes cytotoxic T cell-resistant HIV reservoirs to elimination ev vivo. JCI, 2020. PMID: 32027622; Have Cells Harboring the HIV Reservoir Been Immunoedited? Front Immunol, 2019. PMID: 31447850. Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery. Nat Biotechnol, 2018 PMID: 29985479; Cytotoxic T cells use mechanical force to potentiate target cell killing. Cell, 2016 PMID: 26924577.
- Immunotherapy during the acute SHIV infection of macaques confers long-term suppression of viremia. J Exp Med. 2021 PMID: 32966579; Combination of anti-HIV-1 antibody therapy is associated with increased virus-specific T cell immunity. Nat Med, 2020 PMID: 32015556;
• Ph.D. with a background in immunology, HIV persistence, or immunoengineering.
• Evidence of productivity from publications in high-quality journals originating from Ph.D. or postdoctoral work. Manuscripts that are accepted for publication in high-quality journals will also be considered as evidence of productivity.
• Significant expertise in other cell culture and techniques, and the manipulation of T- or NK-cells
• Capable of working independently with appropriate supervision on assigned projects as well as in a team.
• Excellent verbal and written communication skills in English with good organizational and analytical abilities.
• Excellent organizational skills, self-motivation, and creativity.
*Candidates who meet the above criteria are encouraged to apply. Please email CV and the names and contact information for 3 references to Dr. R. Brad Jones, email@example.com
Weill Cornell Medicine is a comprehensive academic medical center that's committed to excellence in patient care, scientific discovery, and the education of future physicians in New York City and around the world. Our doctors and scientists-faculty from Weill Cornell Medical College, Weill Cornell Graduate School of Medical Sciences, and the Weill Cornell Physician Organization-are engaged in world-class clinical care and cutting-edge research that connect patients to the latest treatment innovations and prevention strategies. Located in the heart of the Upper East Side's scientific corridor, Weill Cornell Medicine's powerful network of collaborators extends to its parent university Cornell University; to Qatar, where an international campus offers a U.S. medical degree; and to programs in Tanzania, Haiti, Brazil, Austria and Turkey. Our medical practices serve communities throughout New York City, and our faculty provide comprehensive care at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, NewYork- Presbyterian/Lower Manhattan Hospital, and NewYork-Presbyterian/Queens. At Weill Cornell Medicine, we work together to treat each individual, not just their conditions or illnesses, as we strive to deliver the finest possible care for our patients - the center of everything we do. Weill Cornell Medicine is an Equal Employment Opportunity Employer. Weill Cornell Medicine provides equal employment opportunities to all qualified applicants without regard to race, sex, sexual orientation, gender identity, national origin, color, age, religion, protected veteran or disability status, or genetic information.